Methylprednisolone infusion in early severe ARDS: It is pretty, but is it art?

Chest

Volumn 132, Issue 3, 2007, Pages 1096-

  Salluh, Jorge I F ^a   Soares, Marcio ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE;

ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NOTE; TREATMENT OUTCOME;

GLUCOCORTICOIDS; HUMANS; INFUSIONS, INTRAVENOUS; METHYLPREDNISOLONE; RESEARCH DESIGN; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 35448982677     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.07-1338     Document Type: Letter

References (5)

1. Vincent JL. Evidence-based medicine in the ICU: important advances and limitations. Chest 2004; 126:592-600
2. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007; 131:913-920 (Pubitemid 46446892)
3. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131:954-963 (Pubitemid 46608692)
4. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34:22-30 (Pubitemid 43032376)
5. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684